Abstract
Maternal infection during pregnancy is associated with increased risk for neurodevelopmental disorders. Lipopolysaccharide (LPS) or saline was administered to rats to model maternal infection, and levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in maternal plasma, placenta, amniotic fluid, fetal liver/spleen, fetal brain, and cerebral cortex after birth were determined by ELISA or semiquantitative Western blot analysis. BDNF expression was significantly increased in the fetal brain (p=0.039); NGF expression was significantly increased in neonatal cortex (p=0.0009). Neurotrophic factor expression was also altered in other tissues of the maternal-fetal unit. Abnormal expression of neurotrophic factors represents a potential mechanism through which maternal infection increases risk for neurodevelopmental disorders.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Animals, Newborn
-
Brain / embryology
-
Brain / immunology
-
Brain / metabolism*
-
Brain-Derived Neurotrophic Factor / antagonists & inhibitors
-
Brain-Derived Neurotrophic Factor / biosynthesis*
-
Brain-Derived Neurotrophic Factor / blood
-
Escherichia coli Infections / blood
-
Escherichia coli Infections / immunology
-
Escherichia coli Infections / metabolism*
-
Female
-
Fetus
-
Injections, Intraperitoneal
-
Lipopolysaccharides / toxicity
-
Liver / embryology
-
Liver / immunology
-
Liver / metabolism
-
Male
-
Maternal-Fetal Exchange / immunology*
-
Nerve Growth Factor / biosynthesis*
-
Placenta / immunology
-
Placenta / metabolism
-
Pregnancy
-
Pregnancy Complications, Infectious / blood
-
Pregnancy Complications, Infectious / immunology
-
Pregnancy Complications, Infectious / metabolism*
-
Rats
-
Rats, Sprague-Dawley
-
Spleen / embryology
-
Spleen / immunology
-
Spleen / metabolism
-
Tumor Necrosis Factor-alpha / biosynthesis
-
Up-Regulation / immunology
Substances
-
Brain-Derived Neurotrophic Factor
-
Lipopolysaccharides
-
Tumor Necrosis Factor-alpha
-
Nerve Growth Factor